Cytokinetics’ heart disease drug meets main goal in late-stage study

(Reuters) -Cytokinetics said on Tuesday its experimental heart disease drug met the main goal in a late-stage study.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shailesh Kuber)

Brought to you by www.srnnews.com